James Howard Tonsgard to Dose-Response Relationship, Drug
This is a "connection" page, showing publications James Howard Tonsgard has written about Dose-Response Relationship, Drug.
Connection Strength
0.033
-
Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma. J Clin Oncol. 2019 12 10; 37(35):3446-3454.
Score: 0.033